午夜寻花

Annual report pursuant to Section 13 and 15(d)

Assets And Liabilities Measured At Fair Value (Details)

v3.3.1.900
Assets And Liabilities Measured At Fair Value (Details) - USD ($)
1 Months Ended 12 Months Ended 14 Months Ended 16 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Oct. 31, 2015
Dec. 31, 2015
Oct. 31, 2013
Oct. 17, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Realized and unrealized gains (losses) on financial instruments, net $ (140,000,000) $ 38,000,000 $ 295,000,000
Payments for (Proceeds from) Derivative Instrument, Investing Activities 322,000,000 72,000,000 59,000,000
1.375% Cash Convertible Senior Notes due 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt face amount $ 1,000,000,000
1.375% Cash Convertible Senior Notes due 2023 | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt face amount $ 1,000,000,000
Fair Value Option Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Realized and unrealized gains (losses) on financial instruments, net (151,000,000) 80,000,000 306,000,000
Convertible Notes Payable | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Realized and unrealized gains (losses) on financial instruments, net (5,000,000) 12,000,000 (17,000,000)
Bond Hedge Change in Fair Value | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Realized and unrealized gains (losses) on financial instruments, net 23,000,000 (89,000,000) (1,000,000)
Other Financial Instruments | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Realized and unrealized gains (losses) on financial instruments, net $ (7,000,000) $ 35,000,000 $ 7,000,000
Forward Contracts | Live Nation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Maximum shares to be purchased 15,900,000 15,900,000
Weighted average stock price shares purchased by counterparty 24.93
Payments for (Proceeds from) Derivative Instrument, Investing Activities $ 396,000,000